Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial

Authors: José Leiva-Fernández, Francisca Leiva-Fernández, Antonio García-Ruiz, Daniel Prados-Torres, Pilar Barnestein-Fonseca

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

Therapeutic adherence of patients with chronic obstructive pulmonary disease (COPD) is poor. This study evaluated the effectiveness of a multifactorial intervention on improving the therapeutic adherence in chronic obstructive pulmonary disease (COPD) patients with scheduled inhalation therapy.

Methods

The study design consisted of a randomised controlled trial in a primary care setting. 146 patients diagnosed with COPD were randomly allocated into two groups using the block randomisation technique. One-year follow-ups with three visits were performed. The intervention consisted of motivational aspects related to adherence (beliefs and behaviour) in the form of group and individual interviews, cognitive aspects in the form of information about the illness and skills in the form of training in inhalation techniques. Cognitive-emotional aspects and training in inhalation techniques were reinforced during all visits of the intervention group. The main outcome measure was adherence to the medication regimen. Therapeutic adherence was determined by the percentage of patients classified as good adherent as evaluated by dose or pill count.

Results

Of the 146 participants (mean age 69.8 years, 91.8% males), 41.1% reported adherence (41.9% of the control group and 40.3% of the intervention group). When multifactorial intervention was applied, the reported adherence was 32.4% for the control group and 48.6% for the intervention group, which showed a statistically significant difference (p = 0.046). Number needed to treat is 6.37. In the intervention group, cognitive aspects increased by 23.7% and skilled performance of inhalation techniques increased by 66.4%. The factors related to adherence when multifactorial intervention was applied were the number of exacerbations (OR = 0.66), visits to health centre (OR = 0.93) and devices (OR = 2.4); illness severity (OR = 0.67), beta-2-adrenergic (OR = 0.16) and xantine (OR = 0.19) treatment; activity (OR = 1.03) and impact (OR = 1.03) scales of the Saint George Respiratory Questionnaire.

Conclusion

Application of the multifactorial intervention designed for this study (COPD information, dose reminders, audio-visual material, motivational aspects and training in inhalation techniques) resulted in an improvement in therapeutic adherence in COPD patients with scheduled inhalation therapy.

Trial registration

Current Controlled Trials ISRCTN18841601.
Appendix
Available only for authorised users
Literature
1.
go back to reference Decramer M, Janssenns W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 2012, 379: 1341-1351. 10.1016/S0140-6736(11)60968-9.CrossRefPubMed Decramer M, Janssenns W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 2012, 379: 1341-1351. 10.1016/S0140-6736(11)60968-9.CrossRefPubMed
2.
go back to reference Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, On behalf of the BOLD Collaborative Research Group: International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet. 2007, 370: 741-750. 10.1016/S0140-6736(07)61377-4.CrossRefPubMed Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, On behalf of the BOLD Collaborative Research Group: International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet. 2007, 370: 741-750. 10.1016/S0140-6736(07)61377-4.CrossRefPubMed
3.
go back to reference Mannino DM, Buist AS: Global burden of COPD: risk factor, prevalence and future trends. Lancet. 2007, 370: 765-773. 10.1016/S0140-6736(07)61380-4.CrossRefPubMed Mannino DM, Buist AS: Global burden of COPD: risk factor, prevalence and future trends. Lancet. 2007, 370: 765-773. 10.1016/S0140-6736(07)61380-4.CrossRefPubMed
4.
go back to reference Soriano JB, Miravitlles M, Borderías L, Duran-Tauleria E, Garcıía-Río F, Martínez J, Montemayor T, Muñoz L, Piñeiro L, Sánchez G, Serra J, Soler-Cataluña JJ, Torres A, Viejo JL, Sobradillo-Peña V, Ancochea J: Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes. Arch Bronconeumol. 2010, 46 (10): 522-530. 10.1016/j.arbres.2010.06.008.CrossRefPubMed Soriano JB, Miravitlles M, Borderías L, Duran-Tauleria E, Garcıía-Río F, Martínez J, Montemayor T, Muñoz L, Piñeiro L, Sánchez G, Serra J, Soler-Cataluña JJ, Torres A, Viejo JL, Sobradillo-Peña V, Ancochea J: Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes. Arch Bronconeumol. 2010, 46 (10): 522-530. 10.1016/j.arbres.2010.06.008.CrossRefPubMed
6.
go back to reference Jemal A, Ward E, Hao Y: Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005, 294: 1255-1259. 10.1001/jama.294.10.1255.CrossRefPubMed Jemal A, Ward E, Hao Y: Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005, 294: 1255-1259. 10.1001/jama.294.10.1255.CrossRefPubMed
7.
go back to reference DiMatteo MR: Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004, 42: 200-209. 10.1097/01.mlr.0000114908.90348.f9.CrossRefPubMed DiMatteo MR: Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004, 42: 200-209. 10.1097/01.mlr.0000114908.90348.f9.CrossRefPubMed
9.
go back to reference Rand CS, Nides M, Cowles MK, Wise RA, Connett J: Long-term metered-dose inhaler adherence in a clinical trial: the lung health study research group. Am J Respir Crit Care Med. 1995, 152: 580-588. 10.1164/ajrccm.152.2.7633711.CrossRefPubMed Rand CS, Nides M, Cowles MK, Wise RA, Connett J: Long-term metered-dose inhaler adherence in a clinical trial: the lung health study research group. Am J Respir Crit Care Med. 1995, 152: 580-588. 10.1164/ajrccm.152.2.7633711.CrossRefPubMed
10.
go back to reference Kesten S, Flanders J, Serby C: Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest. 2000, 118: 191S-192S. Kesten S, Flanders J, Serby C: Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest. 2000, 118: 191S-192S.
11.
go back to reference van Grunsven PM, van Schayck CP, van Deuveren M, Herwaarden CL, Akkermans RP, van Weel C: Compliance during long term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma. 2000, 37: 225-234. 10.3109/02770900009055445.CrossRefPubMed van Grunsven PM, van Schayck CP, van Deuveren M, Herwaarden CL, Akkermans RP, van Weel C: Compliance during long term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma. 2000, 37: 225-234. 10.3109/02770900009055445.CrossRefPubMed
12.
go back to reference Bender BG, Pedan A, Varasteh LT: Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006, 118: 899-904. 10.1016/j.jaci.2006.07.002.CrossRefPubMed Bender BG, Pedan A, Varasteh LT: Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006, 118: 899-904. 10.1016/j.jaci.2006.07.002.CrossRefPubMed
13.
go back to reference Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM: Persistence with inhaled corticosteroid therapy in daily practice. Respir Med. 2004, 98: 752-759. 10.1016/j.rmed.2004.01.014.CrossRefPubMed Breekveldt-Postma NS, Gerrits CM, Lammers JW, Raaijmakers JA, Herings RM: Persistence with inhaled corticosteroid therapy in daily practice. Respir Med. 2004, 98: 752-759. 10.1016/j.rmed.2004.01.014.CrossRefPubMed
14.
go back to reference Krigsman K, Nilsson JL, Ring L: Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf. 2007, 16: 441-448. 10.1002/pds.1321.CrossRefPubMed Krigsman K, Nilsson JL, Ring L: Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf. 2007, 16: 441-448. 10.1002/pds.1321.CrossRefPubMed
15.
go back to reference Restrepo R, Alvarez M, Wittnebel L, Sorenson H, Wettstein R, Vines D, Sikkema-Ortiz J, Gardner DD, Wilkins RL: Medication adherence issues in patients treated for COPD. Int J COPD. 2008, 3: 371-384. Restrepo R, Alvarez M, Wittnebel L, Sorenson H, Wettstein R, Vines D, Sikkema-Ortiz J, Gardner DD, Wilkins RL: Medication adherence issues in patients treated for COPD. Int J COPD. 2008, 3: 371-384.
16.
go back to reference Agh T, Inotai A, Meszaros A: Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011, 82: 328-334. 10.1159/000324453.CrossRefPubMed Agh T, Inotai A, Meszaros A: Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011, 82: 328-334. 10.1159/000324453.CrossRefPubMed
17.
go back to reference Gallefoss F, Bakke P: How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. Am J Respir Crit Care Med. 1999, 160: 2000-2005. 10.1164/ajrccm.160.6.9901028.CrossRefPubMed Gallefoss F, Bakke P: How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. Am J Respir Crit Care Med. 1999, 160: 2000-2005. 10.1164/ajrccm.160.6.9901028.CrossRefPubMed
18.
go back to reference Gallefoss F, Bakke P, Kjaerrgaard P: Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 159: 812-817. 10.1164/ajrccm.159.3.9804047.CrossRefPubMed Gallefoss F, Bakke P, Kjaerrgaard P: Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 159: 812-817. 10.1164/ajrccm.159.3.9804047.CrossRefPubMed
19.
go back to reference Worth H, Dhein Y: Does patient education modify behaviour in the management of COPD?. Patient Educ Couns. 2004, 52: 267-270. 10.1016/S0738-3991(03)00101-0.CrossRefPubMed Worth H, Dhein Y: Does patient education modify behaviour in the management of COPD?. Patient Educ Couns. 2004, 52: 267-270. 10.1016/S0738-3991(03)00101-0.CrossRefPubMed
20.
go back to reference Hesselink AE, Penninx B, van der Windt D, van Duin BJ, de Vries P, Twisk JWR, Bouter LM, van Eijk JTM: Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomised controlled trial. Patient Educ Couns. 2004, 55: 121-128. 10.1016/j.pec.2003.08.007.CrossRefPubMed Hesselink AE, Penninx B, van der Windt D, van Duin BJ, de Vries P, Twisk JWR, Bouter LM, van Eijk JTM: Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomised controlled trial. Patient Educ Couns. 2004, 55: 121-128. 10.1016/j.pec.2003.08.007.CrossRefPubMed
21.
go back to reference Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Intervenciones para mejorar la adherencia a la medicación (Revisión Cochrane traducida). La Biblioteca Cochrane Plus. 2008, Oxford: Update Software Ltd, 2: Available in: http://www.update-software.com. (Translate fromThe Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd) Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Intervenciones para mejorar la adherencia a la medicación (Revisión Cochrane traducida). La Biblioteca Cochrane Plus. 2008, Oxford: Update Software Ltd, 2: Available in: http://​www.​update-software.​com. (Translate fromThe Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd)
22.
go back to reference George J, Kong D, Thoman R, Steward K: Factors associated with medication nonadherence in patients with COPD. Chest. 2005, 128: 3198-3204. 10.1378/chest.128.5.3198.CrossRefPubMed George J, Kong D, Thoman R, Steward K: Factors associated with medication nonadherence in patients with COPD. Chest. 2005, 128: 3198-3204. 10.1378/chest.128.5.3198.CrossRefPubMed
23.
go back to reference Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F: Efficacy and Safety of a multifactor intervention to improve therapeutic adherence in patients with Chronic Obstructive Pulmonary Disease (COPD): protocol for the ICEPOC study. Trials. 2011, 12: 40-10.1186/1745-6215-12-40.CrossRefPubMedPubMedCentral Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F: Efficacy and Safety of a multifactor intervention to improve therapeutic adherence in patients with Chronic Obstructive Pulmonary Disease (COPD): protocol for the ICEPOC study. Trials. 2011, 12: 40-10.1186/1745-6215-12-40.CrossRefPubMedPubMedCentral
24.
go back to reference Brown JB: The use of focus groups in clinical research. Doing Qualitative Research. Edited by: Crabtree BF, Miller WL. 1999, Thousand Oaks. CA: Sage, 109-124. Brown JB: The use of focus groups in clinical research. Doing Qualitative Research. Edited by: Crabtree BF, Miller WL. 1999, Thousand Oaks. CA: Sage, 109-124.
25.
go back to reference Lizarraga S, Ayarra M: Entrevista motivacional. Ann San Navarra. 2001, S2: 43-53. Lizarraga S, Ayarra M: Entrevista motivacional. Ann San Navarra. 2001, S2: 43-53.
27.
go back to reference Lehane E, Mc-Carthy G: Medication non-adherence: exploring the conceptual mire. Inter J Nurs Pract. 2009, 15: 25-31. 10.1111/j.1440-172X.2008.01722.x.CrossRef Lehane E, Mc-Carthy G: Medication non-adherence: exploring the conceptual mire. Inter J Nurs Pract. 2009, 15: 25-31. 10.1111/j.1440-172X.2008.01722.x.CrossRef
28.
go back to reference Sackett DL, Haynes RB, Gibson ES: Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975, 1: 1205-1207.CrossRefPubMed Sackett DL, Haynes RB, Gibson ES: Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975, 1: 1205-1207.CrossRefPubMed
29.
go back to reference Piñeiro F, Gil V, Donis M, Orozco D, Pastor A, Merino J: Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria. 1997, 19 (7): 372-376.PubMed Piñeiro F, Gil V, Donis M, Orozco D, Pastor A, Merino J: Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria. 1997, 19 (7): 372-376.PubMed
30.
go back to reference Batalla A, Blanquer R, Ciurana M, García M, Jordi E, Pérez A: Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Aten Primaria. 1984, 1: 185-191. Batalla A, Blanquer R, Ciurana M, García M, Jordi E, Pérez A: Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Aten Primaria. 1984, 1: 185-191.
32.
go back to reference Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, Aguar MC, Khalaf A, Antó JM: Validity and reliability of the St George’s respiratory questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996, 9: 1160-1166. 10.1183/09031936.96.09061160.CrossRefPubMed Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, Aguar MC, Khalaf A, Antó JM: Validity and reliability of the St George’s respiratory questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996, 9: 1160-1166. 10.1183/09031936.96.09061160.CrossRefPubMed
33.
go back to reference Herdman M, Badía X, Berra S: El EuroQoL-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en Atención Primaria. Aten Primaria. 2001, 28: 425-430. 10.1016/S0212-6567(01)70406-4.CrossRefPubMed Herdman M, Badía X, Berra S: El EuroQoL-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en Atención Primaria. Aten Primaria. 2001, 28: 425-430. 10.1016/S0212-6567(01)70406-4.CrossRefPubMed
35.
go back to reference Laforest L, Denis F, van Ganse E, Ritleng C, Saissier C, Passante N, Devouassoux G, Chatté G, Freymond N, Pacheco Y: Correlates of adherence to respiratory drugs in COPD patients. Prim Care Resp J. 2010, 19: 148-154. 10.4104/pcrj.2010.00004. Laforest L, Denis F, van Ganse E, Ritleng C, Saissier C, Passante N, Devouassoux G, Chatté G, Freymond N, Pacheco Y: Correlates of adherence to respiratory drugs in COPD patients. Prim Care Resp J. 2010, 19: 148-154. 10.4104/pcrj.2010.00004.
36.
go back to reference Khodur MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC: Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012, 68: 1365-1373. 10.1007/s00228-012-1279-5.CrossRef Khodur MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC: Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012, 68: 1365-1373. 10.1007/s00228-012-1279-5.CrossRef
37.
go back to reference Peces-Barba G, Barberà JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardimg J, López Varela V, Monsó E, Montemayor T, Viejo JL: Guía Clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol. 2008, 44: 271-281.CrossRefPubMed Peces-Barba G, Barberà JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardimg J, López Varela V, Monsó E, Montemayor T, Viejo JL: Guía Clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol. 2008, 44: 271-281.CrossRefPubMed
38.
go back to reference Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F: Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med. 2011, 11: 6-10.1186/1471-2466-11-6.CrossRefPubMedPubMedCentral Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F: Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med. 2011, 11: 6-10.1186/1471-2466-11-6.CrossRefPubMedPubMedCentral
39.
go back to reference Fernández AM, Bujalance MJ, Leiva F, Martos F, García A, Prados D: Correlación entre medidas de salud subjetivas y objetivas en pacientes con enfermedad pulmonar obstructiva crónica (EPOC). Aten Primaria. 2001, 28: 579-589. 10.1016/S0212-6567(01)70457-X.CrossRef Fernández AM, Bujalance MJ, Leiva F, Martos F, García A, Prados D: Correlación entre medidas de salud subjetivas y objetivas en pacientes con enfermedad pulmonar obstructiva crónica (EPOC). Aten Primaria. 2001, 28: 579-589. 10.1016/S0212-6567(01)70457-X.CrossRef
40.
go back to reference Alvarez-Gutierrez FJ, Miravitlles M, Calle M, Gobartt E, López F, Martín A, the EIME Study Group: Impact of chronic obstructive pulmonary disease on activities of daily living: results of the multicenter EIME study. Arch Bronconeumol. 2007, 43 (2): 64-72. 10.1157/13098416.CrossRefPubMed Alvarez-Gutierrez FJ, Miravitlles M, Calle M, Gobartt E, López F, Martín A, the EIME Study Group: Impact of chronic obstructive pulmonary disease on activities of daily living: results of the multicenter EIME study. Arch Bronconeumol. 2007, 43 (2): 64-72. 10.1157/13098416.CrossRefPubMed
41.
go back to reference Leiva F, Barnestein P, Vidal F, Leiva J, García A, Prados JD: Adecuación terapéutica de pacientes con EPOC en Atención Primaria ¿Es posible diagnosticar el cumplimiento terapéutico en la práctica clínica habitual?. Med Fam Andal. 2008, 9: 147-160. Leiva F, Barnestein P, Vidal F, Leiva J, García A, Prados JD: Adecuación terapéutica de pacientes con EPOC en Atención Primaria ¿Es posible diagnosticar el cumplimiento terapéutico en la práctica clínica habitual?. Med Fam Andal. 2008, 9: 147-160.
42.
go back to reference Foreman MG, Zhang L, Murphy J, Hansel N, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL, and the COPDGene Investigators: Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD gene study. Am J Respir Crit Care Med. 2011, 184: 414-420. 10.1164/rccm.201011-1928OC.CrossRefPubMedPubMedCentral Foreman MG, Zhang L, Murphy J, Hansel N, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL, and the COPDGene Investigators: Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD gene study. Am J Respir Crit Care Med. 2011, 184: 414-420. 10.1164/rccm.201011-1928OC.CrossRefPubMedPubMedCentral
43.
go back to reference Sorheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL: Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010, 65: 480-485. 10.1136/thx.2009.122002.CrossRefPubMed Sorheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL: Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010, 65: 480-485. 10.1136/thx.2009.122002.CrossRefPubMed
44.
go back to reference Grupo de trabajo de la guía de práctica clínica sobre Atención Integral al paciente con Enfermedad Pulmonar Obstructiva Crónica (EPOC). Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y Sociedad Española de Medicina de Familia (semFYC). 2010, Available: http://www.separ.es Grupo de trabajo de la guía de práctica clínica sobre Atención Integral al paciente con Enfermedad Pulmonar Obstructiva Crónica (EPOC). Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y Sociedad Española de Medicina de Familia (semFYC). 2010, Available: http://​www.​separ.​es
45.
go back to reference Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011, Available: http://www.goldcopd.org. (Accessed Sept 2012) Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011, Available: http://​www.​goldcopd.​org. (Accessed Sept 2012)
46.
go back to reference Esteban C, Moraza J, Aburto M, Quintana JM y Capelastegui A: Description of a sample of patients with chronic obstructive pulmonary disease treated at hospital-supervised respiratory medicine services at primary care centers. Arch Bronconeumol. 2003, 39 (11): 485-490. 10.1016/S0300-2896(03)75437-4.CrossRefPubMed Esteban C, Moraza J, Aburto M, Quintana JM y Capelastegui A: Description of a sample of patients with chronic obstructive pulmonary disease treated at hospital-supervised respiratory medicine services at primary care centers. Arch Bronconeumol. 2003, 39 (11): 485-490. 10.1016/S0300-2896(03)75437-4.CrossRefPubMed
47.
go back to reference Viejo-Bañuelos JL, Pueyo-Bastida A, Fueyo-Rodríguez A: Características de los pacientes ambulatorios con EPOC en la práctica clínica diaria: el proyecto español E4. Respir Med. 2006, 100: 2137-2143. 10.1016/j.rmed.2006.03.043.CrossRefPubMed Viejo-Bañuelos JL, Pueyo-Bastida A, Fueyo-Rodríguez A: Características de los pacientes ambulatorios con EPOC en la práctica clínica diaria: el proyecto español E4. Respir Med. 2006, 100: 2137-2143. 10.1016/j.rmed.2006.03.043.CrossRefPubMed
48.
go back to reference Miravitlles M, Soler-Cataluña JJ, Calle M, Molinae J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Piñera P, Simón A, López-Campos JL, Soriano JB, Ancochea J: Guía Española de la EPOC (GesEPOC): tratamiento farmacológico de la EPOC estable. Arch Bronconeumol. 2012, 48 (7): 247-257. 10.1016/j.arbres.2012.04.001.CrossRefPubMed Miravitlles M, Soler-Cataluña JJ, Calle M, Molinae J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Piñera P, Simón A, López-Campos JL, Soriano JB, Ancochea J: Guía Española de la EPOC (GesEPOC): tratamiento farmacológico de la EPOC estable. Arch Bronconeumol. 2012, 48 (7): 247-257. 10.1016/j.arbres.2012.04.001.CrossRefPubMed
49.
go back to reference DunbarJacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Diswell WM: Adherence in chronic disease. Annu Rev Nurs Res. 2000, 18: 48-90.PubMed Dunbar­Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Diswell WM: Adherence in chronic disease. Annu Rev Nurs Res. 2000, 18: 48-90.PubMed
50.
go back to reference Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M, on behalf of the Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri (AIPO): Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011, 105: 930-938. 10.1016/j.rmed.2011.01.005.CrossRefPubMed Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M, on behalf of the Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri (AIPO): Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011, 105: 930-938. 10.1016/j.rmed.2011.01.005.CrossRefPubMed
52.
go back to reference Melani AS: Inhalatory therapy training: a priority challenge for the physician. Acta Bio-Med. 2007, 78: 233-245. Melani AS: Inhalatory therapy training: a priority challenge for the physician. Acta Bio-Med. 2007, 78: 233-245.
53.
go back to reference Leiva-Fernández F, Leiva-Fernández J, Zubeldia-Santoyo F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P: Efficacy of two educational interventions about inhalation techniques in patients with Chronic Obstructive Pulmonary Disease (COPD): a preference study. Trials. 2012, 13: 64-10.1186/1745-6215-13-64.CrossRefPubMedPubMedCentral Leiva-Fernández F, Leiva-Fernández J, Zubeldia-Santoyo F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P: Efficacy of two educational interventions about inhalation techniques in patients with Chronic Obstructive Pulmonary Disease (COPD): a preference study. Trials. 2012, 13: 64-10.1186/1745-6215-13-64.CrossRefPubMedPubMedCentral
54.
go back to reference Stephen Rennard MD: Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging. Available at: http://www.uptodate.com (accessed April 2013) Stephen Rennard MD: Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging. Available at: http://​www.​uptodate.​com (accessed April 2013)
55.
go back to reference Reardon JZ, Lareau SC, ZuWallack R: Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006, 119: S32-S37. 10.1016/j.amjmed.2005.12.021.CrossRef Reardon JZ, Lareau SC, ZuWallack R: Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006, 119: S32-S37. 10.1016/j.amjmed.2005.12.021.CrossRef
56.
go back to reference Kunz R, Oxman AD: The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 1998, 17: 1185-1190.CrossRef Kunz R, Oxman AD: The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 1998, 17: 1185-1190.CrossRef
57.
go back to reference García Pérez AM, Leiva Fernández F, Martos Crespo F, García Ruiz AJ, Prados Torres D, Sánchez de la Cuesta y Alarcón F: Cómo diagnosticar el cumplimiento terapéutico en Atención Primaria?. Med Fam (And). 2000, 1: 13-19. García Pérez AM, Leiva Fernández F, Martos Crespo F, García Ruiz AJ, Prados Torres D, Sánchez de la Cuesta y Alarcón F: Cómo diagnosticar el cumplimiento terapéutico en Atención Primaria?. Med Fam (And). 2000, 1: 13-19.
58.
go back to reference van Onzenoort HAW, Verberk WJ, Kessels A, Kroon A, Neef C, van der Kuy PH, Leeuw PW: Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild to moderate hypertension. Am J Hypert. 2010, 23: 149-154. 10.1038/ajh.2009.207.CrossRef van Onzenoort HAW, Verberk WJ, Kessels A, Kroon A, Neef C, van der Kuy PH, Leeuw PW: Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild to moderate hypertension. Am J Hypert. 2010, 23: 149-154. 10.1038/ajh.2009.207.CrossRef
59.
go back to reference Cabello JB, Pozo F: Métodos de investigación en cardiología clínica(X): estudios de evaluación de las pruebas diagnósticas en cardiología. Rev Esp Cardiol. 1997, 50: 507-519. Cabello JB, Pozo F: Métodos de investigación en cardiología clínica(X): estudios de evaluación de las pruebas diagnósticas en cardiología. Rev Esp Cardiol. 1997, 50: 507-519.
60.
go back to reference Cl T, Modina D: Lung decline in COPD. Int J COPD. 2012, 7: 95-99. Cl T, Modina D: Lung decline in COPD. Int J COPD. 2012, 7: 95-99.
61.
go back to reference Tashking D: Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications. Curr Opin Pulm Med. 2013, 19: 116-124. 10.1097/MCP.0b013e32835d8ea4.CrossRef Tashking D: Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications. Curr Opin Pulm Med. 2013, 19: 116-124. 10.1097/MCP.0b013e32835d8ea4.CrossRef
Metadata
Title
Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial
Authors
José Leiva-Fernández
Francisca Leiva-Fernández
Antonio García-Ruiz
Daniel Prados-Torres
Pilar Barnestein-Fonseca
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-70

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue